おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
BioNumerik Pharmaceuticals
company
About
BioNumerik Pharmaceuticals discovers, develops and commercializes drugs for treating cancer.
- 51 - 100
Highlights
Details
- Last Funding Type
- Corporate Round
- Last Funding Money Raised
- $52M
- Industries
- Biotechnology,Health Care,Medical Device,Pharmaceutical
- Founded date
- Jan 1, 1992
- Number Of Employee
- 51 - 100
- Operating Status
- Active
BioNumerik Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drugs that help in the treatment of cancer. The company’s two oncology drug candidates, Tavocept and BNP1350, are in late-stage clinical development. BioNumerik Pharmaceuticals, Inc. was founded in 1992 and is based in San Antonio, Texas.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$52M
BioNumerik Pharmaceuticals has raised a total of
$52M
in funding over 2 rounds. Their latest funding was raised on
Oct 8, 2004 from a Corporate Round round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 8, 2004 | Corporate Round | $52M | 1 |
Takeda
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
BioNumerik Pharmaceuticals is funded by 1 investors.
Takeda
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Takeda
|
Yes | Corporate Round |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
